1773
Dural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with vincristine sulfate, prednisone, and asparaginase.
 two children with acute lymphoblastic leukemia: Subject; two: Subject.Population; children: Subject.Age; Dural sinus thrombosis: Effect; induction treatment with vincristine sulfate, prednisone, and asparaginase: Treatment; vincristine sulfate: Treatment.Drug; prednisone: Treatment.Drug; asparaginase: Treatment.Drug; acute lymphoblastic leukemia: Treatment.Disorder; vincristine sulfate: Combination.Drug; prednisone: Combination.Drug; asparaginase: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 two children with acute lymphoblastic leukemia: Subject; two: Subject.Population; children: Subject.Age; Dural sinus thrombosis: Effect; induction treatment with vincristine sulfate, prednisone, and asparaginase: Treatment; vincristine sulfate: Treatment.Drug; prednisone: Treatment.Drug; asparaginase: Treatment.Drug; acute lymphoblastic leukemia: Treatment.Disorder; vincristine sulfate: Combination.Drug; prednisone: Combination.Drug; asparaginase: Combination.Drug